TOKYO, JAPAN - The Nihon Kohden Group has established a response headquarters to address COVID-19. And we have formulated basic policies as follows for conducting our business activities. (1) Health and safety of employees at work and their families as the top priority. (2) Fulfilling our responsibility to supply products and services to maintain the medical care system. The following is the status of our response at the moment.
The Company has confirmed seven cases of COVID-19, one at the Tokorozawa Office and six at the Tomioka Production Center. The Tokorozawa Office has resumed operations on March 31. In addition, we have promoted telecommuting and required employees who are suspected of close contact with those infected to stay at home. At the Tomioka Production Center, the entire factory was disinfected on April 5. Production at the Tomioka Production Center will be suspended until April 10 and all employees will be required to stay at home or telecommute to allow their health to be monitored. After confirming the health and safety of our employees, we will discuss with the local health center and determine when to resume operations. Supply of medical equipment during this period will be handled with stock from the Eastern Japan Logistics Center.
At the Nihon Kohden Group, we are singularly focused on helping advancing healthcare around the world, and we have been committed to aiding healthcare professionals in fighting this pandemic since it began.
The information contained on this site may be changed, modified or supplemented at any time without notice.
